Arterial Hypertension


Stem cell therapy has pronounced positive effect in treatment of arterial hypertension (elevated blood pressure). In particular, at the EmCell clinic patients with primary arterial hypertension grade II with frequent arterial crises receive transplantation of fetal stem cells of ectodermal and mesenchymal origin.

Prior to transplantation, continuous hypotensive therapy regimen is selected; that allowed for preventing hypertensive crises, and diastolic pressure stabilizes at the level no higher than 90 mm Hg.

In 3–5 months after transplantation of fetal stem cells, all patients demonstrate stable decline in blood pressure and reduction of hypotensive therapy by approximately 50%. Over time, 85% of patients lose the need for hypotensive therapy.

All patients note positive effect of treatment that is about disappearance of headache, stabiliziation and normalization of blood pressure and sleep, improved mental ability and sexual potency (both in men and women), return of vivacity – signs of rejuvenation.

Duration of arterial hypertension treatment course at the EmCell clinic, as a rule, totals 2 days.


Comments



Name
E-mail
Enter
the number

Guestbook

About fetal
stem cells
Contacts FAQs